BIOMAT Database Logo BIOMAT Database Logo

Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population. 1988

R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, LA 70112.

Twenty epileptic outpatients, aged 5-20 years and taking either phenobarbital or phenytoin for anticonvulsant therapy, were evaluated for femoral neck area bone mineral content and bone mineral density using dual photon absorptiometry. Duration of treatment averaged 51.4 months (range, 9-124 months). A group of 20 normal children who were matched for age, sex, and race served as controls. There were no statistically significant differences between the femoral neck area bone mineral densities of the epileptic patients as compared to the controls. There were also no correlations between duration of anticonvulsant therapy and bone mineral density, nor any differences in bone mineral density values when comparing epileptic patients taking phenobarbital with those patients taking phenytoin.

UI MeSH Term Description Entries
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005272 Femur Neck The constricted portion of the thigh bone between the femur head and the trochanters. Femoral Neck,Neck, Femoral,Neck, Femur
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Effects of Cushing disease on bone mineral density in a pediatric population.
June 2010, The Journal of pediatrics,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Bone mineral density, vitamin D and anticonvulsant therapy.
September 2000, Arquivos de neuro-psiquiatria,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Effects of a 'drug holiday' on bone mineral density and bone turnover marker during bisphosphonate therapy.
May 2013, Journal of bone metabolism,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children.
January 1994, Brain & development,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Bone Mineral Density to Assess Pediatric Bone Health in Drug Development.
November 2017, Therapeutic innovation & regulatory science,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Decreased bone mineral density in the pediatric renal transplant population.
October 2003, Pediatric transplantation,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Effects of estrogen/androgen therapy on bone mineral density parameters.
March 2001, The Journal of reproductive medicine,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells.
January 2000, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Effects of urinary barium exposure on bone mineral density in general population.
October 2023, Environmental science and pollution research international,
R W Timperlake, and S D Cook, and K A Thomas, and A F Harding, and J T Bennett, and J S Haller, and R M Anderson
Nafarelin therapy in endometriosis: long-term effects on bone mineral density.
November 1994, American journal of obstetrics and gynecology,
Copied contents to your clipboard!